Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
ChemPartner, a CRO based in Shanghai, has reportedly...
Last week, two China biopharmas made announcements about...
It was another significant week for investments in China...
For the readers of ChinaBio® Today, stories about the...
Eastern China's Yangtze River Delta is expected to host...
LEAD Therapeutics of California has a very unusual...
Sanofi-Aventis announced a 600 million RMB ($90 million)...
Shanghai ChemPartner has expanded its drug discovery...
Shanghai ChemPartner Co., Ltd. and ELARA Pharmaceuticals...
In an annual review of its business plans, Eli Lilly...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
